Works matching IS 03125963 AND DT 2020 AND VI 59 AND IP 11
Results: 10
Maintenance Immunosuppression in Solid Organ Transplantation: Integrating Novel Pharmacodynamic Biomarkers to Inform Calcineurin Inhibitor Dose Selection.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 11, p. 1317, doi. 10.1007/s40262-020-00923-w
- By:
- Publication type:
- Article
Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Converging Generic Drug Product Development: Bioequivalence Design and Reference Product Selection.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 11, p. 1335, doi. 10.1007/s40262-020-00912-z
- By:
- Publication type:
- Article
Low Bioavailability of Oral Tacrolimus Suspension in Pediatric Kidney Transplant Patients.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Population Modelling of Dexmedetomidine Pharmacokinetics and Haemodynamic Effects After Intravenous and Subcutaneous Administration.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Population Pharmacokinetic-Pharmacodynamic Relationships of Sarilumab Using Disease Activity Score 28-Joint C-Reactive Protein and Absolute Neutrophil Counts in Patients with Rheumatoid Arthritis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 11, p. 1433, doi. 10.1007/s40262-020-00897-9
- By:
- Publication type:
- Article
A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Drug–Drug–Gene Interaction Model of Metformin and Cimetidine in Healthy Adults and Renally Impaired Individuals.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 11, p. 1419, doi. 10.1007/s40262-020-00896-w
- By:
- Publication type:
- Article
Metabolism and Pharmacokinetic Drug–Drug Interaction Profile of Vericiguat, A Soluble Guanylate Cyclase Stimulator: Results From Preclinical and Phase I Healthy Volunteer Studies.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 11, p. 1407, doi. 10.1007/s40262-020-00895-x
- By:
- Publication type:
- Article
Pipamperone Population Pharmacokinetics Related to Effectiveness and Side Effects in Children and Adolescents.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 11, p. 1393, doi. 10.1007/s40262-020-00894-y
- By:
- Publication type:
- Article